Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DT Capital Partners

Founders Joe Tian Roman Shaw

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 125
Average round size
info
The average size of a deal this fund participated in
$17M
Portfolio companies 103
Rounds per year 6.94
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 11
Key employees 9
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • E-Commerce
  • Medical
  • Biotechnology
  • Information Technology
Summary

The venture was found in Asia in China. The leading representative office of defined VC is situated in the Shanghai.

Among the most successful fund investment fields, there are E-Commerce, Medical. Among the various public portfolio startups of the fund, we may underline 91 Boyuan Wireless, Mofang Gongyu, Xiaodian The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

We also calculated 9 valuable employees in our database.

The increased amount of exits for fund were in 2013. Deals in the range of 10 - 50 millions dollars are the general things for fund. The typical startup value when the investment from DT Capital Partners is 100-500 millions dollars. Comparing to the other companies, this DT Capital Partners performs on 22 percentage points less the average number of lead investments. Considering the real fund results, this VC is 1 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the DT Capital Partners, startups are often financed by Tiger Fund, Ceyuan Ventures, Shunwei Capital. The meaningful sponsors for the fund in investment in the same round are Tiger Fund, Tencent Holdings, Northern Light Venture Capital. In the next rounds fund is usually obtained by Samsung Ventures, Formation 8, Tiger Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DT Capital Partners:
Typical Co-investors
DT Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DT Capital Partners:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Worg Pharmaceuticals

Biotechnology
$170M29 Jun 2023 Shangcheng District, Zhejiang, China

Drug Farm

Biotechnology
$27M16 May 2023 Shanghai, China

Parylene

$8M30 Jan 2023 Jiading, Shanghai, China

STARTDT

$15M01 Dec 2022 -

Beilai Bio

$46M15 Apr 2022 Irvine, California, United States

CytoNiche

Biotechnology
Health Care
$46M03 Mar 2022 Dongcheng District, Beijing, China

Deep Blue Aerospace

Software
$30M18 Jan 2022 China, Beijing, China

Going-Link

Enterprise
$100M26 Nov 2021 Shanghai, China

STARTDT

$30M19 Nov 2021 -

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DT Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 125
Average round size 17M
Rounds per year 6.94
Peak activity year 2016
Lead investments 16
Follow on index 0.14
Exits 11
Group Appearance index 0.82

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Worg Pharmaceuticals

Biotechnology
$170M29 Jun 2023 Shangcheng District, Zhejiang, China

Drug Farm

Biotechnology
$27M16 May 2023 Shanghai, China

Parylene

$8M30 Jan 2023 Jiading, Shanghai, China

STARTDT

$15M01 Dec 2022 -

Beilai Bio

$46M15 Apr 2022 Irvine, California, United States

CytoNiche

Biotechnology
Health Care
$46M03 Mar 2022 Dongcheng District, Beijing, China

Deep Blue Aerospace

Software
$30M18 Jan 2022 China, Beijing, China

Going-Link

Enterprise
$100M26 Nov 2021 Shanghai, China

STARTDT

$30M19 Nov 2021 -
Crunchbase icon

Content report

The following text will be sent to our editors: